Our data showed an increased expression in seven of the subunits of proteasome (PSMA4,5; PSMB2,9,10; PSMD14 and PSME1) in PBMCs from COVID-19 patients, suggesting a potential increase in proteasome activity, since other studies have already related an overexpression of proteasome subunits with a higher proteasome activity [53,54]. This evidence concerns the gene PSMB2 and COVID-19.